Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
European Journal of Heart Failure|September 1, 2024
Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trialHenri Lu, Brian L Claggett, Milton Packer, et al.
JAMA Cardiology|August 30, 2024
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
JACC. Heart Failure|January 23, 2026
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into ActionElise L Shalowitz, Pardeep Jhund, Mitchell A Psotka, et al.
American Journal of Cardiovascular Disease|November 24, 2025
Effectiveness of nurse-led video monitoring for maintaining self-care in heart failure patients: study protocol for a randomized clinical trialOmar Pereira De Almeida Neto, Izadora Vieira Araújo, Maria Eduarda de Pádua Alcântara, et al.
European Journal of Heart Failure|April 27, 2026
Modification of the association between age and mortality in heart failure by frailty statusCaroline Hartwell Garred, Mariam Elmegaard, Daniel Mølager Christensen, et al.
Journal of the American Heart Association|March 12, 2024
Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016Pauline Knigge, Sørine Lundberg, Jarl E Strange, et al.
Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JAMA Cardiology|October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JACC. Heart Failure|July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF TrialMauro Gori, Michele Senni, Brian Claggett, et al.
Pageof 4